Gold nanoparticles-loaded anti-miR221 enhances antitumor effect of sorafenib in hepatocellular carcinoma cells
Hongqiao Cai(First Hospital of Jilin University), Bai Ji(Jilin University)
Cited by 38
Related Papers
Targeting the PD-L1/DNMT1 axis in acquired resistance to sorafenib in human hepatocellular carcinoma
|Oncology Reports|2017|92